Cargando…

Elevation of Serum Ferritin is Associated with the Outcome of Patients with Newly Diagnosed Multiple Myeloma

BACKGROUND/AIMS: Serum ferritin is a marker of acute phase reactions and iron storage. In addition, hematologic malignancies are associated with elevated serum ferritin levels. Other studies have suggested that ferritin is a surrogate for advanced disease and has an impact on relapse, because elevat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Moo-Kon, Chung, Joo-Seop, Seol, Young-Mi, Shin, Ho-Jin, Choi, Young-Jin, Cho, Goon-Jae
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784982/ https://www.ncbi.nlm.nih.gov/pubmed/19949737 http://dx.doi.org/10.3904/kjim.2009.24.4.368

Ejemplares similares

Influence of Lactate Dehydrogenase and Cyclosporine A Level on the Incidence of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation
por: Song, Moo-Kon, et al.
Publicado: (2009)

Outcome of Immunosuppressive Therapy with Helicobacter pylori Eradication Therapy in Patients with Chronic Idiopathic Thrombocytopenic Purpura
por: Song, Moo-Kon, et al.
Publicado: (2008)

The risk factors for herpes zoster in bortezomib treatment in patients with multiple myeloma
por: Yi, Yang-Seon, et al.
Publicado: (2010)

Predictive Value of Post-Transplant Bone Marrow Plasma Cell Percent in Multiple Myeloma Patients Undergone Autologous Transplantation
por: Hwang, In Hye, et al.
Publicado: (2011)

Evaluation of prognostic factors in patients with relapsed AML: Clonal evolution versus residual disease
por: Kim, Hyojeong, et al.
Publicado: (2016)

Frontline therapy for newly diagnosed patients with multiple myeloma
por: Jung, Sung-Hoon, et al.
Publicado: (2020)

Hypersensitivity to Mosquito Bites Associated with Natural Killer Cell–derived Large Granular Lymphocyte Lymphocytosis: A Case Report in Korea
por: Chung, Joo Seop, et al.
Publicado: (2003)

Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple Myeloma
por: Batsukh, Khishigjargal, et al.
Publicado: (2017)

Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma
por: Hsu, Pei, et al.
Publicado: (2015)

A Case of Rosai-Dorfman Disease with Highly Elevated Serum Ferritin
por: Rew, Sung-Yoon, et al.
Publicado: (2012)

Oprozomib in patients with newly diagnosed multiple myeloma
por: Hari, Parameswaran, et al.
Publicado: (2019)

Daratumumab in untreated newly diagnosed multiple myeloma
por: Abdallah, Nadine, et al.
Publicado: (2019)

Acquired platelet dysfunction in newly diagnosed myeloma
por: Mortimer, Joshua, et al.
Publicado: (2021)

A Focus on Newly Diagnosed Multiple Myeloma
por: Brigle, Kevin, et al.
Publicado: (2022)

P934: THE EFFECTS OF EXTRAMEDULLARY DISEASE ON OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
por: Tao, Yi, et al.
Publicado: (2023)

Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions
por: Dignass, Axel, et al.
Publicado: (2018)

Review of thalidomide in the treatment of newly diagnosed multiple myeloma
por: Cavallo, Federica, et al.
Publicado: (2007)

Laboratory Features of Newly Diagnosed Multiple Myeloma Patients
por: Hussain, Azhar, et al.
Publicado: (2019)

Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
por: Libby, Edward, et al.
Publicado: (2020)

The Changes in Early Phase Insulin Secretion in Newly Diagnosed, Drug Naive Korean Prediabetes Subjects
por: Rhee, Sang Youl, et al.
Publicado: (2010)

Elevated Serum Ferritin Is Associated with Reduced Survival in Amyotrophic Lateral Sclerosis
por: Nadjar, Yann, et al.
Publicado: (2012)

Ability of serum ferritin to diagnose iron deficiency anemia in an elderly cohort
por: Babaei, Mansour, et al.
Publicado: (2017)

Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease
por: Kim, Sung Hoon, et al.
Publicado: (2021)

High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients
por: Dong, Mengmeng, et al.
Publicado: (2022)

Ferritin as a predictor of decline in residual renal function in peritoneal dialysis patients
por: Hur, Soon Mi, et al.
Publicado: (2014)

Clinical significance of granule‐containing myeloma cells in patients with newly diagnosed multiple myeloma
por: Suzuki, Kazuhito, et al.
Publicado: (2016)

Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
por: Hassan Zafar, Mir Sadaqat, et al.
Publicado: (2018)

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
por: Landgren, Ola, et al.
Publicado: (2019)

Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas
por: Stork, Martin, et al.
Publicado: (2022)

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
por: Sanchez, Larysa, et al.
Publicado: (2021)

Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma
por: Dimopoulos, Meletios A., et al.
Publicado: (2020)

The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients
por: Yao, Weiqin, et al.
Publicado: (2023)

Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and (18)F-FDG PET/CT
por: Cho, Hee Jeong, et al.
Publicado: (2021)

Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels
por: Cunha, Burke A., et al.
Publicado: (2010)

Gemcitabine, Etoposide, Cisplatin, and Dexamethasone in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
por: Kim, Ki-Hyang, et al.
Publicado: (2009)

Development and validation of prognostic implications of chromosome abnormalities algorithm for newly diagnosed multiple myeloma
por: Luo, Tiancheng, et al.
Publicado: (2020)

Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
por: Kong, Doo-Sik, et al.
Publicado: (2016)

Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patients
por: Lin, Wen‐Ying, et al.
Publicado: (2022)

ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma
por: Park, Sung-Soo, et al.
Publicado: (2023)

Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer.
por: Pattanapanyasat, K., et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_qqbnag3ugi25r0st0j2brus0j1